HIV-1 drug resistance and associated risk factors in patients with antiretroviral therapy failure in Chongqing, China, 2019–2023
Table 2
Prevalence of drug resistance mutations across HIV-1 subtypes among patients with virologic failure in Chongqing, 2019–2023.